Found: 10
Select item for more details and to access through your institution.
The inhibitory receptors PD1, Tim3, and A2aR are highly expressed during mesoCAR T cell manufacturing in advanced human epithelial ovarian cancer.
- Published in:
- Cancer Cell International, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12935-023-02948-0
- By:
- Publication type:
- Article
PX-478, an HIF-1α inhibitor, impairs mesoCAR T cell antitumor function in cervical cancer.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1357801
- By:
- Publication type:
- Article
Hersintuzumab: A novel humanized anti-HER2 monoclonal antibody induces potent tumor growth inhibition.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 2, p. 171, doi. 10.1007/s10637-017-0518-0
- By:
- Publication type:
- Article
Crosstalk between autophagy and metabolic regulation of (CAR) T cells: therapeutic implications.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1212695
- By:
- Publication type:
- Article
PGE2-EP2/EP4 signaling elicits mesoCAR T cell immunosuppression in pancreatic cancer.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1209572
- By:
- Publication type:
- Article
Genetic Modification of Cytokine Signaling to Enhance Efficacy of CAR T Cell Therapy in Solid Tumors.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.738456
- By:
- Publication type:
- Article
Chimeric Antigen Receptor (CAR) T Cell Therapy for Metastatic Melanoma: Challenges and Road Ahead.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 6, p. 1450, doi. 10.3390/cells10061450
- By:
- Publication type:
- Article
Development of a Novel Inhibitory Chimeric Anti-HER2 Monoclonal Antibody.
- Published in:
- Iranian Journal of Immunology, 2019, v. 16, n. 1, p. 26, doi. 10.22034/IJI.2019.39404
- By:
- Publication type:
- Article
Polyclonal Antibody against Different Extracellular Subdomains of HER2 Induces Tumor Growth Inhibition in vitro.
- Published in:
- Iranian Journal of Immunology, 2017, v. 14, n. 3, p. 200
- By:
- Publication type:
- Article
Simultaneous targeting of Tim3 and A2a receptors modulates MSLN-CAR T cell antitumor function in a human cervical tumor xenograft model.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1362904
- By:
- Publication type:
- Article